Assessing The Gravity And Working With Authorities To Reduce Counterfeit Pharmaceuticals In Emerging Markets

09:10 Case Study: Preventing Counterfeit With Effective External And Internal Anti-Counterfeiting Methodologies

• Building an effective anti-counterfeiting strategy: from global strategy to local implementation
• Identifying and utilising global opportunities and expertise
• Making effective use of an international network and specialised laboratories
• Ensuring you get the most out of local teams of national experts in close networks

Axel Fritz Meyer
Head of Complaint Service and Quality Support
Sanofi-Aventis

09:50 EFPIA European Vision: Fighting Counterfeiting With Serialisation - Learning From The Sweden Pilot

• Giving a recap of the approaches that were tested during the EFPIA pilot in Sweden
• Evaluating the results of the pilot and what learning points can be taken away from it
• Assessing what learning can be gained and how they can be translated to create a best practice approach to mass serialisation in Europe
• Discussing current thinking on the issues to address as we approach serialisation in Europe

Grant Courtney
Global and European Serialisation Lead
GSK and EFPIA Representative

11:00 Technology Spotlight Session

Ensuring the supply chain is secure and winning the war against counterfeiters requires innovative and sophisticated technology. In this session we explore the role of technology in the fight against counterfeit medicines.

For information on sponsorship opportunities such as this session, please call +44 (0) 207 368 9300 or email enquiries@iqpc.co.uk

11:40 Securing The Pharmaceutical Supply Chain: How Global Standards Enable Traceability And Visibility

• Assessing emerging requirements worldwide
• Review of current product identification standards
• Analysing how global harmonistion can be achieved
• Working with (inter-)governmental and regulatory bodies to advance standardisation

Jan Denecker
Marketing Manager Healthcare
GS1 Global Office

12:20 Pharmaceutical Counterfeiting: Assessing The Realities And Handling The Challenges

• Lies, damned lies and statistics: the realities of pharmaceutical anti-counterfeiting
• Questioning the idea that technology and packaging gives only a false sense of security
• Identifying the areas really under threat from counterfeiting
• Looking to the future: how the war can really be won

Andrew Jackson
Deputy Head of Global Corporate Security
Novartis

14:20 Roundtable Discussion Sessions

A: The Internet as a Platform for Counterfeiters

• Assessing the Realistic Risks and Enforcing Your Rights
• Are online sales increasing or on the decline?
• Are webshops more or less of a concern now than the physical supply chain?
• How can you effectively protect your products and patients online?

B: Effective Communication with Patients to Facilitate Self-Authentication

• How much should patients be informed of security measures on products?
• What should patients be allowed to authenticate and what should be kept back for the companies?

Sebastien Mauel
Head of Product Security Strategy
Merck Serono

C: Ensuring Compliance and Coverage with New Legislation: the Legal Perspective

• How do recent court cases affect pharma anticounterfeiting strategy?
• What impact do circumstances such as WTO complaints have on the industry?
• What is the realistic impact of the new EU Commission legislation on counterfeit medicines?

Chris Verleye
Senior Counsel
Johnson & Johnson

15:00 Roundtable Feedback

15:20 Ensuring The Legitimate Supply Chain Is Secure: The Impact Of A New Legal Framework

• Discussing new legal requirements that impact the pharmaceutical supply chain
• Questioning points left open in the legislation and legal frameworks
• Assessing the practical impact of the directive on wholesalers
• Future protective measures: a wholesaler’s perspetive

Monika Derecque-Pois
Secretary General
GIRP

16:20 Viewing And Using Anti-Counterfeiting As A Strategic Business Opportunity

• Viewing counterfeiters as commercial competitors as well as criminals
• Using product security to differentiate your products
• Improving business processes when integrating brand protection strategies
• Getting closer to your customer through anti-counterfeiting

Mark Davison
CEO
Blue Sphere Health Ltd.

17:00 Chairman’s Closing Comments And Close Of Conference